Page last updated: 2024-08-24

tenofovir and s 8932

tenofovir has been researched along with s 8932 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's5 (100.00)2.80

Authors

AuthorsStudies
Han, J; Izawa, K; Konno, H; Sato, T; Soloshonok, VA1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Duan, Y; Zhou, C; Zhu, HL1
Eades, W; Shen, Y; Yan, B1
Byakika-Kibwika, P; D'Avolio, A; Kaboggoza, JP; Lamorde, M; Waitt, C; Walimbwa, SI1

Reviews

1 review(s) available for tenofovir and s 8932

ArticleYear
Tailor-made amino acids in the design of small-molecule blockbuster drugs.
    European journal of medicinal chemistry, 2021, Aug-05, Volume: 220

    Topics: Amino Acids; Chemistry, Pharmaceutical; Drug Design; Humans; Molecular Structure; Small Molecule Libraries

2021

Trials

1 trial(s) available for tenofovir and s 8932

ArticleYear
An open-label, randomized, single intravenous dosing study to investigate the effect of fixed-dose combinations of tenofovir/lamivudine or atazanavir/ritonavir on the pharmacokinetics of remdesivir in Ugandan healthy volunteers (RemTLAR).
    Trials, 2021, Nov-23, Volume: 22, Issue:1

    Topics: Adenosine Monophosphate; Adult; Alanine; Anti-HIV Agents; Atazanavir Sulfate; Healthy Volunteers; Humans; Lamivudine; Oligopeptides; Pyridines; Ritonavir; Tenofovir; Uganda

2021

Other Studies

3 other study(ies) available for tenofovir and s 8932

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Advance of promising targets and agents against COVID-19 in China.
    Drug discovery today, 2020, Volume: 25, Issue:5

    Topics: Adenine; Adenosine Monophosphate; Alanine; Amides; Antimalarials; Antiviral Agents; Betacoronavirus; China; Chloroquine; Clinical Trials as Topic; Cobicistat; Coronavirus 3C Proteases; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cysteine Endopeptidases; Dibenzothiepins; Drug Combinations; Drug Discovery; Drug Therapy, Combination; Emtricitabine; Humans; Hydroxychloroquine; Indoles; Lopinavir; Medicine, Chinese Traditional; Morpholines; Oseltamivir; Oxazines; Pandemics; Pneumonia, Viral; Pyrazines; Pyridines; Pyridones; Ritonavir; RNA-Dependent RNA Polymerase; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Tenofovir; Thiepins; Triazines; Viral Nonstructural Proteins

2020
Remdesivir potently inhibits carboxylesterase-2 through covalent modifications: signifying strong drug-drug interactions.
    Fundamental & clinical pharmacology, 2021, Volume: 35, Issue:2

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Carboxylesterase; COVID-19 Drug Treatment; Drug Interactions; Enzyme Inhibitors; Humans; Microsomes; Pharmaceutical Preparations; Tenofovir

2021